Terms: = Brain cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Clinical Outcome
3 results:
1. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract] [Full Text] [Related]
3. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
[TBL] [Abstract] [Full Text] [Related]
